|
Box | Folder
|
Title
|
| |
Research Contracts,
1952-2001 [subseries]:
|
| |
Proposals,
1955-2001 [subseries]:
|
| 47 |
11 |
Unidentified,
undated
|
| 47 |
12 |
Etiology of viral diarrheas - part III,
undated
|
| 47 |
13 |
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg,
1955
|
| 47 |
14 |
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
c.1964
|
| 47 |
15 |
The isolation of viruses and viral subunits,
1964
|
| 47 |
16 |
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures,
c.1965
|
| 47 |
17 |
Studies on adenovirus vaccines,
c.1965
|
| 47 |
18 |
Biochemical and immunologic investigations of neisseria meningitidis,
1965
|
| 47 |
19 |
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae,
1965
|
| 47 |
20 |
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
1965
|
| 47 |
21 |
Concentration of human hepatitis virus (supplement to NIAID Support of Man program),
1966
|
| 47 |
22 |
Proposed vaccine studies, Kansas City,
1966
|
| 47 |
23 |
Respiratory virus vaccines,
1967
|
| 47 |
24 |
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines,
1967
|
| 47 |
25 |
X-ray crystal structure of adenovirus coat protein,
1969
|
| 47 |
26 |
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971
|
| 47 |
27 |
Studies on hemophilus influenzae b vaccine,
c.1972
|
| 47 |
28 |
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization,
1974
|
| 47 |
29 |
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells,
1975
|
| 47 |
30 |
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection,
1975
|
| 47 |
31 |
Protective efficacy of langat virus vaccines in mice - animal study proposal,
1997
|
| 47 |
32 |
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal,
1999
|
| 47 |
33 |
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice,
2001
|
| 47 |
34 |
Immunogenicity and protective efficacy of langat virus vaccines in mice,
2001
|
| |
Reports,
1952-1998 [subseries]:
|
| 47 |
35-39 |
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati,
1952-1956
|
| 47 |
40 |
Vaccine development program commitments,
1965
|
| 47 |
41 |
Respiratory vaccine development,
1966
|
| 47 |
42 |
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory,
1967
|
| 47 |
43 |
NIAID Molecular Anatomy Program,
1967
|
| 47 |
44 |
Evaluation of a live type 4 adenovirus vaccine,
1967-1968
|
| 47 |
45 |
Acute infectious nonbacterial gastroenteritis,
1973
|
| 47 |
46 |
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies,
1964-1965
|
| 47 |
47 |
6-61-03-032 - Studies on virus and rickettsial diseases,
1953
|
| 47 |
48 |
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
49 |
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
50 |
3A014501B71Q - Communicable diseases - immunology,
c.1966
|
| 47 |
51 |
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines,
1963
|
| 47 |
52 |
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus,
1965
|
| 47 |
53 |
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections,
1965
|
| 47 |
54 |
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus,
1967
|
| 47 |
55 |
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus,
1971
|
| 47 |
56 |
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus,
1971
|
| 47 |
57 |
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits,
1972
|
| 48 |
1 |
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines,
1970
|
| 48 |
2 |
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines,
1970
|
| 48 |
3 |
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1969
|
| 48 |
4 |
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines,
1971
|
| 48 |
5-6 |
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971, 1973
|
| 48 |
7 |
N01-AI-01528 - New viruses in relation to clinical diseases,
1968-1972
|
| 48 |
8-9 |
N01-AI-02638 - Operation of a virus vaccine production laboratory,
1980-1981, 1983-1987
|
| 48 |
10 |
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals,
1981
|
| 48 |
11-13 |
N01-AI-05057 - University of Puerto Rico,
1991-1992
|
| 48 |
14-15 |
N01-AI-05067 - Care and housing of AIDS research animals,
1990-1991
|
| 48 |
16 |
N01-AI-17757 - Children's Hospital,
1980-1981
|
| 48 |
17-19 |
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults,
1972-1989
|
| 48 |
20 |
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains,
1974
|
| 48 |
21 |
N01-AI-22508 - Clinical evaluation of influenza virus vaccines,
1974
|
| 48 |
22 |
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . .,
1993-1994
|
| 49 |
1-2 |
N01-AI-32521 - Operation of a virus laboratory in support of LID,
1974-1990
|
| 49 |
3-4 |
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity,
1978
|
| 49 |
5 |
N01-AI-42528 - Influenza research center,
1979
|
| 49 |
6 |
N01-AI-52565,
1985-1987
|
| 49 |
7-8 |
N01-AI-72535 - Establishment of an infectious enteric disease study,
1978-1979
|
| 49 |
9-10 |
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory,
1988-1989
|
| 49 |
11 |
N01-AO-52703 - Care and housing of AIDS research animals,
1997-1998
|
| 49 |
12 |
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research,
1998
|
| 49 |
13 |
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture,
1966
|
| 49 |
14 |
PH-43-62-80 - Production of enterovirus antisera,
1965
|
| 49 |
15 |
PH-43-62-127 - Preparation of immune serum to enteroviruses,
1965
|
| 49 |
16 |
PH-43-62-129 - Standardization of picornavirus immune sera,
1965
|
| 49 |
17-26 |
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine,
1962-1970
|
| 49 |
27-29 |
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance,
1966-1968
|
| 49 |
30-32 |
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines,
1966-1968
|
| 49 |
33 |
PH-43-62-839 - Preparation of mycoplasma antigene and antisera,
1965
|
| 49 |
34-35 |
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children,
1968, 1970
|
| 49 |
36-38 |
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population,
1966-1968
|
| 50 |
1-4 |
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species,
1964-1966
|
| 50 |
5-6 |
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses,
1965, 1967
|
| 50 |
7 |
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells,
1967
|
| 50 |
8 |
PH-43-63-90 - Upper respiratory virus,
1965
|
| 50 |
9 |
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory,
1966
|
| 50 |
10-11 |
PH-43-63-562 - Prevention of viral respiratory infections,
1964, 1968
|
| 50 |
12 |
PH-43-63-563 - Vaccine studies in a children's center,
1968
|
| 50 |
13 |
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection,
1967
|
| 50 |
14-16 |
PH-43-63-582 - Respiratory disease vaccine,
1962-1967
|
| 50 |
17-18 |
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population,
1966, 1968
|
| 50 |
19-20 |
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population,
1967-1968
|
| 50 |
21 |
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus,
1964
|
| 50 |
22 |
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses,
1965
|
| 50 |
23 |
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses,
1965
|
| 50 |
24 |
PH-43-64-529 - Preparation and development of viral reagents,
1965
|
| 50 |
25-27 |
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis,
1966, 1968, 1972
|
| 50 |
28-29 |
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine,
1966-1967
|
| 50 |
30-32 |
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs,
1965-1967
|
| 50 |
33-34 |
PH-43-65-562 - Rhinovirus reference laboratory,
1966-1967
|
| 50 |
35-36 |
PH-43-65-563 - Studies of RSV vaccines,
1966-1967
|
| 50 |
37 |
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents,
1968
|
| 50 |
38-40 |
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections,
1966-1968
|
| 50 |
41 |
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers,
1966
|
| 50 |
42-43 |
PH-43-66-93 - Rubella vaccine development,
1967-1968
|
| 50 |
44 |
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines,
1967
|
| 50 |
45 |
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines,
1968
|
| 50 |
46-47 |
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine,
1967-1968
|
| 50 |
48 |
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents,
1966
|
| 50 |
49 |
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man,
1966-1968
|
| 50 |
50 |
PH-43-66-565 - Development of a live vaccine for human influenza,
1966
|
| 50 |
51-52 |
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants,
1969
|
| 50 |
53-54 |
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions,
1967-1968
|
| 50 |
55 |
PH-43-66-970 - Operation of a tissue culture developmental laboratory,
1967
|
| 50 |
56 |
PH-43-66-971 - Provide for the operation of a serology laboratory,
1967
|
| 50 |
57-58 |
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children,
1968, 1970
|
| 50 |
59-60 |
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers,
1967-1968
|
| 50 |
61 |
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus,
1968
|
| 50 |
62 |
PH-43-67-77 - Biologic and antigenic studies with rubella virus,
1968
|
| 50 |
63 |
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines,
1968
|
| 50 |
64-65 |
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines,
1967
|
| 50 |
66 |
PH-43-67-80 - Studies of rubella vaccine efficacy,
1967
|
| 50 |
67 |
PH-43-67-91 - Research and development of respiratory disease vaccines,
1967-1968
|
| 50 |
68 |
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines,
1973
|
| 50 |
69 |
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis,
1969
|
| 50 |
70-71 |
PH-43-67-745 - Studies of local antibody in respiratory viral immunity,
1967, 1969
|
| 50 |
72 |
PH-43-68-81 - Operation of a rubella virus service laboratory,
1968
|
| 50 |
73 |
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein,
1968
|
| 50 |
74 |
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines,
1968
|
| 51 |
1-4 |
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses,
1968-1975
|
| 51 |
5-6 |
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1968-1969
|
| 51 |
7 |
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus,
1977
|
| 51 |
8 |
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus,
1978-1981
|
